Leukaemia Foundation Research Unit
We are proud to have funded the Leukaemia Foundation Research Unit for more than 20 years, guided by a simple goal to find cures for blood cancers and related disorders and to deliver the benefits to patients as quickly as possible.
Established in 1992, the unit is located at the QIMR Berghofer Medical Research Institute on the Royal Brisbane Hospital campus. This enables the laboratory to draw on other world-class research at the QIMR Berghofer, one of the largest medical research institutes in the southern hemisphere, and first-rate facilities at surrounding hospitals.
The laboratory is led by Professor Andrew Boyd, Professor of Experimental Haematology, who is recognised internationally as a leader in haematological cancer research.
His laboratory seeks to:
- explore the basic causes of these diseases
- use this knowledge to develop novel theories
- improve the expertise needed to rapidly evaluate and implement new ideas.
Currently, the laboratory is exploring the biology of leukaemia and other cancers through studies of leukaemia-associated proteins. These are proteins which are either modified forms of normal proteins or are proteins which are normally not seen on blood cells but are abnormally expressed by leukaemic cells. In some cases these proteins are also expressed on other cancers.
Professor Boyd’s vision is that the lab will become a centre of excellence in molecular biology and the hub of expanding haematological research centre.
To date, the Leukaemia Foundation has invested $8.8 million in the laboratory.
For further information on the unit’s research and recent publications, visit the QIMR Berghofer website.